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1. Introduction 
Angiotensin,II, (Asp-Arg-Val-Tyr-Val (or Ile)- 
I-lis-Pro-Phe), is a natural pressor agent which has 
undergone considerable conformational investigation 
by theoretical energy calculations [ 1] and by physical 
[2] as well as by chemical and biochemical techniques 
[3]. Minimum energy conformational calculations 
have shown a number of possible folded low energy 
conformations for angiotensin-lI [1]. Electrometric 
titrations of [lie s ] -angiotensin-lI and of a number of 
homologs and analogs [4] have been interpreted as 
indicating that the N- and C-terminal ends of [lie s ] 
angiotensin-II are in closer proximity than expected 
in a random coil conformation. It was further proposed 
that intramolecular electrostatic interactions are present 
between the N- and C-termini. Carbon-13 (13C) 
nuclear magnetic resonance studies on [lie s] - 
angiotensin-II have shown that the His-Pro peptide 
bond is in the trans conformation about the peptide 
link; ~3C spin-lattice relaxation time (T1) measure- 
ments indicated that all the a-carbons in the peptide 
backbone have almost equal mobility [5]. The TI 
values are compatible with an overall folded con- 
formation. 
t3C n.m.r, spectroscopy is proving useful in the 
study of conformationally heterogeneous cyclic and 
linear peptides in solution [5-11]. 13C Spin-lattice 
relaxation time studies are gradually increasing our 
knowledge of the relative mobilities [6,8-10] and 
rates of rotation about individual bonds in peptides 
[11] and peptide hormones [5,12]. The purpose of 
the present study is to investigate he conformational 
properties of an angiotensin analogue which is not 
believed to fold to the same extent as does [lie s ] 
angiotensin-II [4]. Such studies are necessary in order 
to relate structure to biological activity. If hormones 
and analogues can display a.number of conformations 
in solution, determination f the nature and relative 
importance of the various conformers may lead to 
greater insight into the conformers which can interact 
with receptor molecules. Furthermore conformational 
heterogeneity may be responsible for different 
activities of peptide hormones in different issues. The 
greater dispersion afforded by high field n.m.r. 
spectrometers has allowed the observation of con- 
formational heterogeneity n [Pro3,Pro s] -angiotensin- 
II. Spin-lattice relaxation times give insight into the 
relative mobilities of individual amino acyl residues. 
2. Materials and methods 
[Pro3,Pro s ] -antiotensin-II was synthesized as pre- 
viously described [4]. The methods used to obtain 
13C chemical shifts and T1 values are described in 
reference [10]. The 13C spectra t 90.5 MHz were 
obtained on a Bruker HX-360 spectrometer at 
Spectrospin AG, Ziirich, with the kind help of 
Mr W. Schittenhelm. All spectra were obtained in 
D2 O; 'pH' values were measured irectly in D20 and 
were corrected for the deuterium isotope ffect at the 
glass electrode [13]. The 'pH' of samples was adjusted 
using CDaCOOH or NH4OH dissolved in D20. 
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3. Results and discussion 
3.1. Chemical Shifts 
The 13C chemical shifts of [Pro3,Pro s ] -angiotensin- 
II are given in table 1. Assignments were made in part 
by comparison with those observed in [Ile s ] -angiotensin- 
II [5]. However, the presence of proline residues in 
peptides is known to perturb the 13C chemical shifts of 
residues attached to the nitrogen atom of proline [14]. 
The '7-steric' effect of proline results in an upfield 
shift of approx. 1 part per million (ppm) in the 
a-carbon of the residue preceeding proline. To confirm 
the assignments of the various carbon resonances we 
varied the 'pH' of the sample sufficiently to titrate the 
aspartic acid, phenylalanyl and histidyl residues. The 
influence of pH on the ~3C chemical shifts in a peptide 
is confined almost exclusively to the residue under- 
going titration [1,1 5]. In the case of [Pro3,ProS] - 
angiotensin-II this method is not unambiguous 
because the pK a values of the a-carboxyl group of 
phenylalanine (pK a = 3.34) and the/3-carboxyl group 
of aspartic acid (pK a = 3.02) are similar [4]. We 
therefore studied the dipeptide Asp-Phe-NH2 and 
titrated only the aspartic acid residue which allowed 
us to determine the chemical shifts of the aspartyl 
residue in a peptide at all 'pH' values. The 13C 
chemical shifts of the aspartyl residue in Asp-Phe- 
NH2 at 'pH' 0.7 are as follows (in ppm): Asp a-CH, 
50.39./3-CH2, 35.72; T-C=O, 173.54; carbonyl C=O, 
169.33. Titration of the carboxyl group followed by 
that of the amino group yields changes in aspartyl 
resonances only: a-CH, + 2.8; 13-CH2, + 7.6; 3' C=O, 
+ 4.8; carbonyl, + 10.4 ppm (a positive sign indicates 
a downfield shift). The phenylalanyl residue is 
Table 1 
~3C Chemical shifts ain [Pro3,Pro s ]-angiotensin II in I~ O 
Residue 'pH' Residue 'pH' 
1.8 5.2 9.6 1.8 5.2 9.6 
Asp a, CH 50.67 51.59 53.40 Pro aCH 61.58 61.89 61.48 
#CH 2 36.03 38.19 43.32 #CH 2 30.36 30.21 30.05 
"rC=O 173.77 176.97 17.7.63 "rCH~ 25.64 25.59 25.50 
C=O 169.41 170.33 ~-172.8 ~CH 2 49.03 48.90 48.94 
C=O 174.51 174.40 174.4 
Arg c~CH 52.58 52.43 52.71 His aCH 51.45 51.59 51.97 
~CH 2 28.59 28.57 28.89 #CH 2 26.98 27.13 29.30 
3,CH~ 25.06 25.02 25.02 3'C 129.13 129.02 126.64 
~CH 2 41.73 41.7.0 41.74 6CH 134.53 134.68 137.28 
g'C 157.79 eCH 118.77 118.79 119.19 
C=O 172.15 172.21 ~172.8 C=O 170.67 170.91 ~-172.8 
Pro uCH 61.58 61.61 61.48 Pro aCH 61.58 62.04 61.86 
#CH~ 30.36 30.21 30.05 j3CH: 30.36 30.21 30.05 
3,CH 2 25.64 25.59 25.50 7CH2 25.64 25.59 25.50 
~CH 2 49.03 48.90 48.94 ~CH 2 49.03 48.90 48.94 
C=O 174.51 174.40 174.4 C=O 174.88 173.95 173.9 
Tyr aCH 54.00 53.91 53.94 Phe aCH 55.24 57.31 57.23 
#CH 2 36.72 36.71 36.86 ~CH 2 37.51 38.48 38.60 
"yC 129.13 129.28 127.75 3,C 137.58 138.52 138.57 
8CH 131.85 131.82 131.86 ~iCH 130.38 130.47 130.49 
eCH 116.50 116.47 117.15 eCH 129.82 129.57 129.64 
~'C 155.55 155.60 157.80 ~'CH 128.25 127.85 127.93 
C=O 172.50 172.44 ~172.8 C=O 176.70 178.60 178.52 
aChemical shifts are reported in parts per million downfield from external (CH3)4Si. Accuracy of chemical shifts +- 0.05 ppm. 
Carbonyl carbon assignments are tentative. 'pH' values are pH-meter readings in D20 uncorrected for the deuterium isotope 
effect. 
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3 5 Fig.1. ~3C Spectra of [Pro ,Pro ] -angiotensin II (a) Spectral region between 20 and 65 ppm downfield from (CH3)4Si, 25.2 MHz, 
'pH' 5.2, 32 000  scans, 32°C. (b) Same spectral region as in (a), 90.5 MHz, 'pH' 6.0,  39 000  scans, 20°C. (c) Spectral region 
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unperturbed and its chemical shifts are similar to 
those in [Proa,Pro s] -angiotensin-lI at 'pH' 1.8: a-CH, 
56.39;/3-CH2, 37.85; aromatic arbons, 128.34, 
129.88, 130.31,137.37; carbonyl, 176.13 ppm. 
Figure la) shows the 13C spectrum of [Pro3,ProS] - 
angiotensin-II at 25.2 MHz. At this frequency most 
of the resonances of the three prolyl residues are 
degenerate. A number of weak 'extra' resonances are 
present in the spectrum. The resonances which occur 
at 23.2 and 32.4 ppm are typical ofcis isomers of 
proline [ 16]. The approximate amounts of  these 
isomers, as measured from peak intensities vary 
between 10 and 15%, the larger amount being observed 
at higher 'pH'. At 25.2 MHz the cis proline resonances 
from individual proline residues are not resolved and 
one cannot distinguish whether or not all three proline 
residues how 10-15% cis isomer or whether only one 
residue occurs with 30-45% cis isomer. Based on 
studies of other peptides and hormones [7] the former 
possibility appears more likely. This is confirmed by 
the 90.5 MHz spectrum, fig.1 b. The 3' carbon of proline 
shows three resonances for the three cis isomers. The 
fourth weak resonance at highest field is that of 
residual acetate. Caution must be exerted when 
assigning resonances of minor intensity near 23 ppm 
to cis isomers of proline in peptides as often residual 
acetate will occur in the same region. However the 
ambiguity is readily resolved by measurement of
spin-lattice relaxation times. The acetate methyl 
groups show much longer Tl values than do cis 
isomers of proline. The T~ values of cis and trans 
isomers of proline are of the same order of magnitude 
[17,18]. Doubling of lines is also apparent on the 
tyrosyl residue which in [Pro3,Pro s] -angiotensin-II 
is situated between two prolyl residues. These extra 
resonances may result from a cis isomer of tyrosine 
or simply be a long-range steric effect of the cis 
isomers of proline on the chemical shift of tyrosine. 
Comparing spectra of [Proa,Pro s ] -angiotensin-II 
with those of [Ile s] -angiotensin-lI [5] at the same 
'pH' we can evaluate the effect of the proline-sub- 
stitutions on the ~3C chemical shifts. The ~t-,/3-, 3' 
and carbonyl carbons of arginine were shifted upfield 
by 2.1, 1.0, 0.5 and 1.5 ppm respectively. The 
tyrosyl residue also showed changes: t~-CH, -2.1 ; 
/~-CH2, -0 .6 ;  3'-C, + 0.2; 8-CH, + 0.2; carbonyl -1 .5  
ppm. All other resonances were affected by less than 
0.2 ppm. 
Table 2 
~3C Spin-lattice relaxation times in [Pro3,Pro s] -angiotensin D20* 
Position Residue a ~ "y ~ e ~" 
1 Asp 275 a 300 
(500) (500) 
2 Arg 185 (200 270 .370 
(270) (420) (620) (730) 
3 Pro 165 b 210 c 390 d 240 e 
(280 b) (420 c) (540 d) (340 e) 
4 Tyr 160 190 - 235 225 
(240~ (300) - (430) (350) 
5 Pro 165 ° 210 c 390 d 240 e 
(280 b) (420 c) (540 d) (340 e) 
6 His 200 a 180 - 285 215 
(235) (360) - (450) N.O. 
7 Pro 190 210 c 390 d 240 e 
(260) (420 c) (540 d) (340 e) 
8 Phe 236 270 - 335 335 
(365) (470) - (720) (660) 
280 
(430) 
*NT 1 values measured at 67.8 MHz are given in msec; N is the number of directly-bonded hydrogens. The 
hormone concentration was 76 mg/ml in D20, 'pH' 4.1, 25°C. The NT~ values in parentheses were obtained 
at 'pH' 1.1, 40 ° C; Superscripts indicate partially or completely overlapping resonances. 
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3.2. laC Spin-lattice relaxation times 
The laC spin-lattice relaxation times of [Pro a, 
Pro s] -angiotensin-II obtained at 67.9 MHz are given 
in table 2. The data show that the T~ values for all 
parts of the backbone structure of [proa,ProS] - 
angiotensin are quite similar with the exception of 
the terminal residue which show longer T~ values. 
The T~ values of the aspartyl residue are longer than 
those of the phenylalanyl residue, indicating reater 
mobility at the N-terminus than at the C-terminus 
under both sets of conditions. Segmental motion in 
arginine is not inhibited by the adjacent prolyl residue 
nor is rotation about the axis traversing the C~,-C~- 
bond of the tyrosyl residue. However motion about 
this axis in tyrosine is slower than in the C-terminal 
phenylalanyl residue, which was also found for [IleS] - 
angiotensin-II [5]. The prolyl residues how intra- 
cyclic motion which is most pronounced at the 
~,-carbon. The fl- and 6-carbons of proline are equally 
mobile and more mobile than the a-carbon. Although 
direct comparison of the above data with those 
obtained for [lie s] -angiotensin-II should not be made 
due to the differences in experimental conditions, 
we can conclude that the terminal a-carbons in 
[Proa,Pro s ] -angiotensin-II show greater freedom 
relative to the non-terminal carbons than do the 
terminal a-carbons in [IleS]-angiotensin-II. This may 
be a consequence of loosening of the peptide back- 
bone in [Pro3,Pro s ] -angiotensin-II when compared 
to [lie s ] -anglotensin-lI. The difficulty of accurate 
temperature gulation on the high field instruments 
(270 and 360 MHz) during the Tl experiments makes 
direct comparison of data obtained at 'pH' 4.1 and 
pH 1.1 difficult. However, within this uncertainty, 
it is apparent that the mobilities of all carbon atoms 
are considerably greater at 'pH' 1.1. An increase in 
the rate of segmental motion occurs for the arginyl, 
histidyl, and phenylalanyl residues, but little change 
occurs for the aspartyl, prolyl, and tyrosyl residues. 
4. Conclusion 
Our studies have shown that linear peptides can 
show considerable conformational heterogeneity in 
solution. Such facts should be considered when 
testing the biological and pharmacological properties 
of hormone analogs. It may thus be possible to relate 
activity to the relative proportions and to the accessi- 
bility of specific conformers in linear peptide 
hormones. The accessiblity of a number of conforma- 
tions indicates that these conformations differ only 
slightly in energy. Thus, the energy involved in binding 
to the receptor site may well be sufficient o force 
the peptide into a single conformation which is not 
necssarily one of those observed for the unbound 
hormone. 
The T~ measurements have shown that the side 
chains of the residues adjacent to the prolyl residues 
have not undergone any significant motional restric- 
tion due to the presence of the cyclic residues. 
However the a-carbons of the terminal residues 
appear to be more flexible than those located in non- 
terminal positions. This may be a consequence of a 
looser overall backbone conformations in [Pro 3, 
Pro s ] .angiotensin-II than in [lie s] -angiotensin-II. 
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